158 related articles for article (PubMed ID: 33843916)
1. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Barr PM
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
[No Abstract] [Full Text] [Related]
2. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
[No Abstract] [Full Text] [Related]
3. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Evens AM
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
[No Abstract] [Full Text] [Related]
4. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Salles G
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
[No Abstract] [Full Text] [Related]
5. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Davids MS
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
[No Abstract] [Full Text] [Related]
6. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
[No Abstract] [Full Text] [Related]
7. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
[No Abstract] [Full Text] [Related]
8. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
[No Abstract] [Full Text] [Related]
9. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
[No Abstract] [Full Text] [Related]
10. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Jacobson CA
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
[No Abstract] [Full Text] [Related]
11. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
DiPersio JF
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
[No Abstract] [Full Text] [Related]
12. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
[No Abstract] [Full Text] [Related]
13. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):1-24. PubMed ID: 33843917
[No Abstract] [Full Text] [Related]
14. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913
[No Abstract] [Full Text] [Related]
15. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
Awan FT
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
[No Abstract] [Full Text] [Related]
16. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
[No Abstract] [Full Text] [Related]
17. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary.
Straus DJ
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910
[No Abstract] [Full Text] [Related]
18. American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USA.
Talmadge JE
IDrugs; 2007 Feb; 10(2):87-9. PubMed ID: 17285455
[No Abstract] [Full Text] [Related]
19. American Society of Hematology--50th Annual Meeting and Exposition--Part 2.
Cleverley J; Millar E
IDrugs; 2009 Feb; 12(2):66-8. PubMed ID: 19216125
[No Abstract] [Full Text] [Related]
20. Highlights in mantle cell lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Flinn I
Clin Adv Hematol Oncol; 2021 Apr; 19 Suppl 13(4):17-19. PubMed ID: 35290296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
